m2 as a preparative regimen for patients with multiple myeloma undergoing auto-SCT

Overview of attention for article published in Bone Marrow Transplantation, September 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 6 X users

guideline: 2 clinical guideline sources

Readers on

mendeley: 68 Mendeley

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 41,316 followers.

RT @Myeloma_Doc: Randomized study suggests melphalan @ 280 mg/m2 may be more effective as part of auto transplant for #myeloma: http://t.co…

Randomized study suggests melphalan @ 280 mg/m2 may be more effective as part of auto transplant for #myeloma: http://t.co/8NkOTJnO2u.

RT @MediHumdani: MEL200 vs MEL280 in #myeloma http://t.co/uq99T0FmDT

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.